News & Events

Read QuantuMDx’s latest news to stay up to date with the company, its products, solutions and services.

Media Alert

QuantuMDx & Menarini Announce Exclusive Distribution Agreement

Agreement will initially cover the UK and France with potential to expand to other European countries and worldwide NEWCASTLE UPON TYNE, UK, 2 November 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of transformational Point of Care molecular diagnostics, and…

Media Alert

Close up of a hand in a blue medical glove interacting with a touch screen q-poc device

QuantuMDx & Sansure Biotech Enters into Agreement

The agreement sets a roadmap for the commercialisation of Q-POC™ and its assays in China…

Media Alert

QuantuMDx announces webinar: Rising to the challenge

Diagnosing, treating and managing respiratory infections NEWCASTLE UPON TYNE, UK, 5 July 2022. QuantuMDx Group…

News

QuantuMDx Shortlisted for SelectScience Clinical Scientists Awards

NEWCASTLE UPON TYNE, UK, [17 June 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of transformational Point of Care diagnostics, is pleased to announce that Q-POC™ has made the SelectScientists’ Choice Awards shortlist for the Best New Clinical Product of…

Previous Next

CAPTURE-XT explained

Sample cleanup and pathogen concentration

Future development

A novel microfluidic lab-on-a-chip sample clean up and cell concentration technology. Available as a prototype.

Close up of tubercolosis under microscope

Tuberculosis - the challenge

RISK6 explained

Simplified Workflow

Future development

A multiplex PCR laboratory assay to detect host-response-mediated mRNA transcripts present in whole blood. For Research Use Only.

A supercharged platform, with a fast workflow

A smooth user experience with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.

High quality multiplex PCR testing, as simple as a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.

News & Events

QuantuMDx & Menarini Announce Exclusive Distribution Agreement

QuantuMDx & Sansure Biotech Enters into Agreement

QuantuMDx announces webinar: Rising to the challenge

QuantuMDx Shortlisted for SelectScience Clinical Scientists Awards

CAPTURE-XT

TB Host Immune Response Assay (TB-HIRA)

Q-POC Platform

Respiratory Solution